AU2012332211B2 — Methods for treating irritable bowel syndrome (IBS) and infections
Assigned to Salix Pharmaceuticals Ltd · Expires 2016-11-24 · 9y expired
What this patent protects
The present invention provides new methods and kits for the retreatment of IBS, for reducing commonly-occurring infections in patients suffering from hepatic encephalopathy, and for reducing frequency of incidence of
USPTO Abstract
The present invention provides new methods and kits for the retreatment of IBS, for reducing commonly-occurring infections in patients suffering from hepatic encephalopathy, and for reducing frequency of incidence of
Drugs covered by this patent
- Xifaxan (rifaximin) · Bausch Health
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.